Aptargroup (ATR) Current Deferred Revenue (2010 - 2011)

Aptargroup's (ATR) quarterly Current Deferred Revenue came in at $17.2 million in Q4 2011, up 8.63% year-on-year from $15.8 million in Q4 2010, and up 8.63% on a QoQ basis from $15.8 million in Q4 2010.

Aptargroup (ATR) Current Deferred Revenue (2010 - 2011) Analysis & Trends

Aptargroup (ATR) has 2 years of Current Deferred Revenue data on file, last reported at $17.2 million in Q4 2011.

  • On a quarterly basis, Current Deferred Revenue rose 8.63% year-over-year to $17.2 million in Q4 2011; TTM through Dec 2011 was $17.2 million, a 8.63% increase from a year earlier, with the FY2011 full-year figure at $17.2 million, up 8.63% from the prior year.
  • Current Deferred Revenue for Q4 2011 stood at $17.2 million, up from $15.8 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for ATR reached as high as $17.2 million in Q4 2011 and fell as low as $15.8 million in Q4 2010.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn
10 Aptargroup 9.43 Bn 9.23 Bn 351.91 Mn

Historic Data

Download Data
DateValue
Dec 31, 2011 17.16 Mn
Dec 31, 2010 15.80 Mn